Warning: fopen(/home/virtual/enm-kes/journal/upload/ip_log/ip_log_2024-03.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 88 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 89
Radiation Health Institute, Korea Hydro and Nuclear Power Co., Ltd., Seongnam, Korea.
Copyright © 2019 Korean Endocrine Society
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.
AUTHOR CONTRIBUTIONS:
Values are expressed as mean±SD or number (%).
MetS, metabolic syndrome; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; TG, triglyceride; HOMA-IR, homeostatic model assessment of insulin resistance; hs-CRP, high-sensitivity C-reactive protein; PA, physical activity.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; TG, triglyceride; HOMA-IR, homeostatic model assessment of insulin resistance; hs-CRP, high-sensitivity C-reactive protein.
Values are expressed as mean±SD.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; TG, triglyceride; HOMA-IR, homeostatic model assessment of insulin resistance; hs-CRP, high-sensitivity C-reactive protein.
aTotal testosterone (ng/mL): Q1 (≤5.08), Q2 (5.09 to 6.23), Q3 (6.24 to 7.64), Q4 (≥7.65); bSerum homocysteine (µmol/L): Q1 (≥12.21), Q2 (10.51 to 12.20), Q3 (9.11 to 10.50), Q4 (≤9.10).
Model 1, crude odds ratios; Model 2, adjusted for age; Model 3, adjusted for model 2 plus alcohol consumption and smoking status; Model 4, adjusted for model 3 plus high-sensitivity C-reactive protein; Model 5, adjusted for model 4 plus homeostatic model assessment-insulin resistance; Model 6, adjusted for model 5 plus body mass index.